Needham Reiterates Buy on Generation Bio, Maintains $14 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Gil Blum has reiterated a 'Buy' rating on Generation Bio (NASDAQ:GBIO) and maintained a price target of $14.
August 04, 2023 | 1:55 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham analyst Gil Blum has reiterated a 'Buy' rating on Generation Bio and maintained a price target of $14.
The reiteration of a 'Buy' rating by a Needham analyst and the maintenance of a $14 price target indicates a positive outlook for Generation Bio. This could potentially lead to an increase in investor confidence and a positive impact on the stock's short-term price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100